HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metyrapone

An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
Also Known As:
Metopiron; Metopirone; Métopirone; SU 4885; Methbipyranone; Methopyrapone; 1-Propanone, 2-methyl-1,2-di-3-pyridinyl-
Networked: 644 relevant articles (47 outcomes, 60 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Neylan, Thomas C: 5 articles (01/2018 - 09/2003)
2. Otte, Christian: 5 articles (04/2007 - 09/2003)
3. Goeders, Nicholas E: 4 articles (12/2019 - 01/2014)
4. Tufik, Sergio: 4 articles (05/2013 - 04/2008)
5. Yehuda, Rachel: 4 articles (10/2009 - 09/2003)
6. Kellner, Michael: 4 articles (10/2006 - 08/2004)
7. Wiedemann, Klaus: 4 articles (10/2006 - 08/2004)
8. Yassouridis, Alexander: 4 articles (10/2006 - 08/2004)
9. Guignat, Laurence: 3 articles (08/2022 - 04/2013)
10. de Jong, Frank H: 3 articles (01/2019 - 11/2005)

Related Diseases

1. Cushing Syndrome
2. Pituitary ACTH Hypersecretion
3. Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
4. Neoplasms (Cancer)
5. Pituitary Diseases (Disease, Anterior Pituitary)

Related Drugs and Biologics

1. Hydrocortisone (Cortisol)
2. Adrenocorticotropic Hormone (ACTH)
3. Steroids
4. Aminoglutethimide (Cytadren)
5. Ketoconazole (Nizoral)
6. Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)
7. Dexamethasone (Maxidex)
8. Corticosterone
9. Mitotane (Lysodren)
10. Cytokines

Related Therapies and Procedures

1. Therapeutics
2. Radiotherapy
3. Drug Therapy (Chemotherapy)
4. Liver Transplantation
5. Injections